- Home
- Advocacy
- Latest News and Practice Data
- Register Today for LDT Webinar Happening This Thursday, Nov.7: Ready Your Laboratory for the FDA’s Stage 1: Adverse Event Reporting Requirement
Under the Food and Drug Administration’s (FDA) new regulation, laboratories with laboratory-developed tests (LDTs) must have a process in place for adverse event reporting starting May 6, 2025. The CAP’s second webinar in our series on the rule will discuss existing accreditation requirements and ways laboratories can comply with the medical device-related adverse event reporting requirements. Accreditation experts will review best practices and review real world scenarios. Join us this Thursday, Nov. 7, Noon-1 PM CT to learn more!
Speakers
- Bobbi S. Pritt, MD, FCAP, chair, Council on Scientific Affairs
- Earle S. Collum, MD, FCAP, chair, Council on Accreditation